PRESS RELEASE published on 11/10/2023 at 06:30, 2 years 2 months ago Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences
PRESS RELEASE published on 10/10/2023 at 07:30, 2 years 3 months ago Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
PRESS RELEASE published on 09/29/2023 at 07:30, 2 years 4 months ago Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 5 months ago Formycon reports successful first half of 2023
PRESS RELEASE published on 08/29/2023 at 07:30, 2 years 5 months ago Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
PRESS RELEASE published on 08/23/2023 at 07:30, 2 years 5 months ago Formycon hosts conference call on financial and earnings position for H1 2023
PRESS RELEASE published on 08/21/2023 at 13:42, 2 years 5 months ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/07/2023 at 08:00, 2 years 5 months ago Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar
PRESS RELEASE published on 07/26/2023 at 07:30, 2 years 6 months ago Formycon reports on the regular Annual General Meeting
PRESS RELEASE published on 06/29/2023 at 07:30, 2 years 7 months ago Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the U.S. Food and Drug Administration (FDA)
Published on 02/05/2026 at 01:35, 5 hours 42 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 7 hours 17 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 8 hours 52 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 15 hours 2 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/05/2026 at 07:00, 16 minutes ago Aurubis AG: Aurubis achieves quarterly result in line with market expectations and upgrades 2025/26 forecast
Published on 02/05/2026 at 07:00, 16 minutes ago FY2025: Resilient rental income and record new money in Asset Management ensure stable FFO I of CHF 4.22 per share; higher dividend of CHF 3.50 per share proposed
Published on 02/05/2026 at 07:00, 17 minutes ago Rational AG reports growth of 8 percent after exchange rate adjustments – preliminary figures for the 2025 fiscal year
Published on 02/05/2026 at 07:00, 17 minutes ago CGTN: Vision 2030: China's tech blueprint reshaping global innovation
Published on 02/05/2026 at 07:00, 17 minutes ago SIG Group: New CEO Mikko Keto to start on 1 March 2026
Published on 02/04/2026 at 18:04, 13 hours 13 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 13 hours 13 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 13 hours 32 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 13 hours 32 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
